"FLAME" - machine learning model developed to predict SLE flares. Data from 28,433 SLE pts (2011-2022) looked at clinica

Tweet Author

Tweet Content

"FLAME" - machine learning model developed to predict SLE flares. Data from 28,433 SLE pts (2011-2022) looked at clinical & social determinants of health (SDoH) to predict 3 mo flare risk. AUROC = 0.67; SHAP analysis identified HA, OBS, & pyuria as predictors. Is this the https://t.co/6Eqqc9w2oV

29 July 2025

Top 20 Best Rheumatology Hospitals - 2025

U.S. News & World Report has published its Best Hospitals for 2025, listing the best among many specialties, including rheumatology. Each year, U.S. News ranks hospitals in 15 specialties and for the 8th year in a row, Johns Hopkins Hospital in Baltimore has been named the top hospital for rheumatology by U.S. News & World Report.

PsA is worse in women--why? 100 PsA pts, serum study of differentially expressed proteins - 20 times more sex-specific

Tweet Author

RheumNow

Tweet Content

PsA is worse in women--why? 100 PsA pts, serum study of differentially expressed proteins - 20 times more sex-specific DEPs in PsA males than females (PsA vs controls). In women leukotriene A-4; and in men IL-36, NEK7 & PIK3CA/PIK3R1 were significant predictors. https://t.co/JzI1n6Hf5G

CKD & Osteoporosis Rx Revisited (7.25.2025) Dr. Jack Cush reviews the news, journal and FDA updates from this past

Tweet Author

RheumNow

Tweet Content

CKD & Osteoporosis Rx Revisited (7.25.2025) Dr. Jack Cush reviews the news, journal and FDA updates from this past week on RheumNow. https://t.co/k78DRpWIJS https://t.co/aYKvIhmJN1

Links

CKD & Osteoporosis Rx Revisited (7.25.2025) | RheumNow https://buff.ly/AXWIDvm

Heart Attack No Longer the Leading Cause of Death in America . Journal of AHA reports that heart disease mortality in th

Tweet Author

RheumNow

Tweet Content

Heart Attack No Longer the Leading Cause of Death in America . Journal of AHA reports that heart disease mortality in the United States dropped by 66 percent over the past five decades, driven largely by a dramatic decline in fatal heart attacks. https://t.co/whMQSMozVv https://t.co/ik6uydmspF

Links

Mortalities from America's top cause of death have dropped 66 percent—Study https://buff.ly/7zfIh9d

28 July 2025

HCQ Preserves Renal Function in Lupus Nephritis

Lupus nephritis patients on long-term therapy with hydroxychloroquine showed significantly less decline in renal function, compared with patients treated otherwise, a 10-year retrospective study indicated.

28 July 2025

Factors Affecting Biologic Use in Rheumatoid Arthritis

A San Francisco Rheumatoid Arthritis Panel cohort survey between 1999–2011, showed numerous sociodemographic, disease, and health characteristics that influenced the initiation of treatment with biologic agents for rheumatoid arthritis (RA).

The University of California, San Francisco Rheumatoid Arthritis Panel Study was the source of data, primarily collected by a structured annual phone survey.

The study included 527 RA patients in 1999, and 229 persons (44%) had received biologic therapies by 2011.

Systemic immune-inflammation index (SII), as a potential biomarker -- computed as platelet count × neutrophil count/lym

Tweet Author

RheumNow

Tweet Content

Systemic immune-inflammation index (SII), as a potential biomarker -- computed as platelet count × neutrophil count/lymphocyte count. SII has been shown to be useful in RA, PsA, SpA, SLE and vasculitis, reflecting disease activity, drug responses & supplements ESR & CRP levels https://t.co/LuFaYbWiWN

Review of risankizumab efficacy & safety included 545 psoriasis pts showing Mean PASI decreased from 14 to 0.5 at 20

Tweet Author

RheumNow

Tweet Content

Review of risankizumab efficacy & safety included 545 psoriasis pts showing Mean PASI decreased from 14 to 0.5 at 208Wk. PASI100 achieved in 33% and 74% at 16Wk & 208Wk. Bio-naïve responded faster bio-experienced pts - only 5 pts D/C for adverse events https://t.co/VklLWpD0SF https://t.co/zZfuiFijd4

Links

https://buff.ly/CmX7hU6

MTX or TNFi use in elderly #RA pts w/in a year of Dx of melanoma was not associated with increased mortality. This inclu

Tweet Author

RheumNow

Tweet Content

MTX or TNFi use in elderly #RA pts w/in a year of Dx of melanoma was not associated with increased mortality. This included melanoma in situ (48%), localized (47%) and regional (5%) melanoma. Steroid use however was assoc w/ reduced survival. https://t.co/QOXfEf51S1 https://t.co/6BPtEV6sOU

Links

https://buff.ly/K94RJtT

Topics

"FLAME" - machine learning model developed to predict SLE flares. Data from 28,433 SLE pts (2011-2022) looked at clinica

Top 20 Best Rheumatology Hospitals - 2025

PsA is worse in women--why? 100 PsA pts, serum study of differentially expressed proteins - 20 times more sex-specific

CKD & Osteoporosis Rx Revisited (7.25.2025) Dr. Jack Cush reviews the news, journal and FDA updates from this past

Heart Attack No Longer the Leading Cause of Death in America . Journal of AHA reports that heart disease mortality in th

Systemic immune-inflammation index (SII), as a potential biomarker -- computed as platelet count × neutrophil count/lym

Review of risankizumab efficacy & safety included 545 psoriasis pts showing Mean PASI decreased from 14 to 0.5 at 20

MTX or TNFi use in elderly #RA pts w/in a year of Dx of melanoma was not associated with increased mortality. This inclu

Do you get our email newsletter?